Canadian Guidelines for the Development of Antidementia Therapies: a Conceptual Summary
Open Access
- 1 February 1995
- journal article
- neurological practice
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 22 (1) , 62-72
- https://doi.org/10.1017/s0317167100040543
Abstract
The magnitude of the problems faced by Canadian society as a result of an aging population has been identified. Perhaps the most important concern related to this greying of Canada is the increasing incidence of dementia and Alzheimer’s disease. Therapeutic options for these disorders have been limited to date. Advances in biotechnology and molecular biology will offer novel approaches to treatment. These and the expansion of more traditional therapeutic avenues require guidelines with the aim of optimizing their development.Keywords
This publication has 109 references indexed in Scilit:
- Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measuresElectroencephalography and Clinical Neurophysiology, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- High resolution EEGBrain Topography, 1993
- Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidolJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Organic mental disorders in HIV-1 infectionAIDS, 1990
- Alzheimer's DiseaseNew England Journal of Medicine, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969